Good afternoon, and welcome to Verastem Oncology's First Quarter 2026 Earnings Conference Call. My name is Daniel, and I will be your call operator today. Please note, this event is being recorded.
Q1 2026 Earnings Call May 7, 2026 8:30 AM EDTCompany ParticipantsRyan Edelman - Vice President of Investor RelationsMark Morelli ...
Q3 2026 guidance -- Revenue of $68 million to $72 million, gross margin of 75% to 76%, adjusted EBITDA of $8 million to $12 million, net income between -$1 million and $3 million, and EPS between ...
Use our mortgage calculators to help you work out how repayments will affect your household finances, if you could save money ...
Growth stocks offer high return potential by leveraging future earnings, but face high volatility. Opt for growth ETFs like Vanguard Small-Cap for diversified low-cost exposure to multiple companies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results